Sort by
CJC-1295 (With DAC) — 10mg
$199.99CJC-1295 (With DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) engineered for research on long-acting endocrine signaling.
The “DAC” (Drug Affinity Complex) component allows the peptide to bind to albumin, extending its duration within experimental systems and enabling the study of prolonged receptor activity.
Researchers use CJC-1295 (With DAC) to investigate extended-release GHRH analog behavior, pituitary signaling cascades, and hormone-regulation modeling.
CJC-1295 (No DAC) — 10mg
$89.99CJC-1295 (No DAC) is a synthetic peptide analog of growth hormone–releasing hormone (GHRH) designed for laboratory research on pituitary signaling pathways.
The “No DAC” version means it does not include the Drug Affinity Complex, resulting in a shorter half-life and more direct examination of its raw biological activity in vitro.
Researchers study this peptide to better understand GHRH-related pathways, cellular communication, and signaling responses associated with growth hormone secretion mechanisms.
GENIQ supplies CJC-1295 (No DAC) strictly for in-vitro scientific research and not for human or animal use.
BPC-157 / TB-500 (10mg / 10mg)
$175.99BPC-157 / TB-500 is a research peptide blend combining two widely studied compounds: BPC-157, a gastric-derived peptide fragment, and TB-500, a synthetic analog of thymosin beta-4 sequences.
Researchers study this combination for its potential influence on cellular repair dynamics, angiogenic pathways, inflammatory processes, and tissue-architecture regulation.
GENIQ supplies this peptide blend strictly for scientific research and not for human or animal use.
BPC-157 (10mg)
$79.99BPC-157 is a synthetic peptide composed of a partial sequence derived from the Body Protection Compound (BPC), a naturally occurring protein fragment found in gastric juice.
In research settings, BPC-157 is examined for its ability to influence cellular signaling involved in tissue responses, angiogenesis processes, and regulatory pathways tied to recovery and repair.
GENIQ provides BPC-157 strictly for controlled scientific research—not for human or animal use.
AOD-9604 (5mg)
$108.99AOD-9604 is a laboratory-designed peptide fragment derived from the 176–191 region of the human growth hormone (HGH) sequence.
It is studied for its interactions with metabolic signaling pathways and its potential influence on lipid-related biochemical activity.
This compound is provided exclusively for controlled scientific research and is not intended for human or animal use.
GLOW BPC-157 / TB-500 / GHK-Cu (10mg / 10mg / 50mg)
$239.99This research blend combines three widely studied peptides: BPC-157, TB-500, and GHK-Cu.
Each compound has been individually investigated for its interactions with biological pathways related to cellular repair, structural tissue regulation, angiogenesis, and inflammatory signaling.
Together, this combination is used in laboratory settings to explore how multiple signaling mechanisms behave when studied simultaneously.
GENIQ provides this blend strictly for scientific research—not for human or animal use.
Retatrutide (30mg)
$375.99Retatrutide is a synthetic multi-agonist peptide designed to target several metabolic signaling receptors simultaneously, including GIP, GLP-1, and glucagon pathways in research environments.
Because of this multi-receptor interaction, Retatrutide is increasingly studied for its role in energy balance, metabolic regulation, glucose control models, and nutrient-sensing biochemical pathways.
GENIQ supplies Retatrutide exclusively for laboratory research purposes—not for human or animal administration.
Retatrutide (20mg)
$299.99Retatrutide is a synthetic multi-agonist peptide designed to target several metabolic signaling receptors simultaneously, including GIP, GLP-1, and glucagon pathways in research environments.
Because of this multi-receptor interaction, Retatrutide is increasingly studied for its role in energy balance, metabolic regulation, glucose control models, and nutrient-sensing biochemical pathways.
GENIQ supplies Retatrutide exclusively for laboratory research purposes—not for human or animal administration.
Retatrutide (10mg)
$175.99Retatrutide is a synthetic multi-agonist peptide designed to target several metabolic signaling receptors simultaneously, including GIP, GLP-1, and glucagon pathways in research environments.
Because of this multi-receptor interaction, Retatrutide is increasingly studied for its role in energy balance, metabolic regulation, glucose control models, and nutrient-sensing biochemical pathways.
GENIQ supplies Retatrutide exclusively for laboratory research purposes—not for human or animal administration.
Tesamorelin (20mg)
$289.99Tesamorelin is a synthetic peptide analog of Growth Hormone–Releasing Hormone (GHRH), specifically engineered as a stabilized form of GHRH 1–44.
Researchers study Tesamorelin for its interactions with GHRH receptors, growth-hormone signaling pathways, metabolic activity, and endocrine regulation models.
GENIQ provides Tesamorelin exclusively for scientific research—not for human or animal use.
MOTS-c (10mg)
$99.99MOTS-c (Mitochondrial-Derived Peptide c) is a short peptide encoded within mitochondrial DNA, rather than nuclear DNA like most human peptides.
Researchers study MOTS-c for its role in cellular metabolism, mitochondrial communication, energy regulation, stress responses, and metabolic-signaling pathways.
GENIQ supplies MOTS-c exclusively for laboratory research—not for human or animal use.
5-Amino-1MQ (10mg)
5-Amino-1MQ (5-Amino-1-methylquinolinium) is a small-molecule research compound studied for its role in cellular metabolism, NAD⁺ regulation pathways, and enzyme-inhibition models.
Researchers frequently evaluate its interaction with NNMT (Nicotinamide N-methyltransferase)—an enzyme associated with metabolic rate, adipocyte biochemistry, and cellular energy processes.
GENIQ supplies 5-Amino-1MQ strictly for scientific research—not for human or animal use.